1. OS05.4.A Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. (5th September 2022) Authors: Schmassmann, P; Roux, J; Dettling, S; Hogan, S; Herter, S; Bacac, M; Shekarian, T; Martins, T A; Ritz, M; Hutter, G Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P06.03.A Combination of EGFRvIII CAR T cell therapy and paracrine GAM modulation for the treatment of GBM. (5th September 2022) Authors: Martins, T A; Tatari, N; Ritz, M; Shekarian, T; Schmassmann, P; Kaymak, D; Hutter, G Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P12.09 Multidimensional Personalized Response Assessment to Microglia Modulators in Gioblastoma Bioreactors. (6th September 2019) Authors: Shekarian, T; Wachnowicz, A; Flammer, J; Paganetti, C; Martins, T; Muraro, M; Schürch, C; Hutter, G Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P17.10.B Identification of mechanisms involved in the recurrence of glioblastoma by transcriptomic, proteomic and spatial profiling analysis. (5th September 2022) Authors: Ritz, M; Shekarian, T; Martins, T; Hogan, S; Schmassmann, P; Burger, B; Hutter, G Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗